PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
Polomar Health Services, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026
- Market cap
- $3.37M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Polomar Health Services's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Daniel Gordon | 117,639,770 | 42.53% | 13D (active) amendment | Sep 30, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Terrence McGill Tierney | President, Director | 141,028 | 0.50% | Sep 17, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Terrence McGill Tierney President, Director | Aug 15, 2025 | Award | +7,695 | $2693.00 | $20.72M | 141,028 |
| Terrence McGill Tierney President, Director | Jul 15, 2025 | Award | +8,333 | $2917.00 | $24.31M | 133,333 |
| Terrence McGill Tierney President, Director | Jun 27, 2025 | Award | +125,000 | $43750.00 | $5.47B | 125,000 |
| Rasmus Refer CEO and CFO, Director, 10% owner | Sep 12, 2023 | Sale | −1,145,000 | $0.10 | $114.50K | 3,855,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.